ETON.OQ - Eton Pharmaceuticals Inc
Eton Pharmaceuticals Inc
Craig HallumEstimate Increase, Price Target Increase

A Lot To Like From The Q4 Update, Including Bullish Medium-Term Targets, With Eyes Fixed On $500M In Revenue By 2030. Raising Price Target To $35 (From $30).

公司
ETON.OQ
日期
2026-03-20
分析师
Mr. Chase Knickerbocker
页数
9 页
需要登录
请登录后购买研报或生成音频内容。